Table of Contents Author Guidelines Submit a Manuscript
Advances in Orthopedics
Volume 2012, Article ID 595027, 5 pages
http://dx.doi.org/10.1155/2012/595027
Clinical Study

The Use of Epoetin-α in Revision Knee Arthroplasty

1Department of Surgery, Temple University, Philadelphia, PA 19140, USA
2Thomas Jefferson University, Philadelphia, PA 19129, USA
3The Richard Stockton College of New Jersey, Pomona, NJ 08240, USA
4Rothman Institute, Egg Harbor Township, NJ 08234, USA
5Thomas Jefferson University Hospital, Philadelphia, PA 19129, USA
6AtlantiCare Regional Medical Center, Egg Harbor Township, NJ 08234, USA

Received 3 February 2012; Revised 5 May 2012; Accepted 6 May 2012

Academic Editor: Christian Bach

Copyright © 2012 Lawrence A. Delasotta et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. J. Callaghan, M. R. O'Rourke, and S. S. Liu, “Blood management: issues and options,” Journal of Arthroplasty, vol. 20, no. 2, pp. 51–54, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Carson, L. Goodnough, and E. Keating, “Blood products: maximal use, conservation pre-deposit blood, when to transfuse and Erythropoietin,” in Proceedings of the 66th Annual Meeting of the American Academy of Orthopaedic Surgeons, Anaheim, Calif, USA, 1999.
  3. E. M. Keating, J. B. Meding, P. M. Faris, and M. A. Ritter, “Predictors of transfusion risk in elective knee surgery,” Clinical Orthopaedics and Related Research, no. 357, pp. 50–59, 1998. View at Google Scholar · View at Scopus
  4. A. Mylod, M. France, D. Muser, and J. Parsons, “Perioperative blood loss associated with total knee arthroplasty. A comparison of procedures performed with and without cementing,” Journal of Bone and Joint Surgery A, vol. 72, no. 7, pp. 1010–1012, 1990. View at Google Scholar · View at Scopus
  5. L. T. Goodnough, M. E. Brecher, M. H. Kanter, and J. P. AuBuchon, “Transfusion medicine—blood transfusion,” The New England Journal of Medicine, vol. 340, no. 6, pp. 438–447, 1999. View at Publisher · View at Google Scholar · View at Scopus
  6. L. Pulido, E. Ghanem, A. Joshi, J. J. Purtill, and J. Parvizi, “Periprosthetic joint infection: the incidence, timing, and predisposing factors,” Clinical Orthopaedics and Related Research, vol. 466, no. 7, pp. 1710–1715, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. G. E. Hill, W. H. Frawley, K. E. Griffith, J. E. Forestner, and J. P. Minei, “Allogeneic aiiogeneic blood transfusion increases the risk of postoperative bacterial infection: a meta-analysis,” Journal of Trauma, vol. 54, no. 5, pp. 908–914, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. J. L. Pierson, T. J. Hannon, and D. R. Earles, “A blood-conservation algorithm to reduce blood transfusions after total hip and knee arthroplasty,” Journal of Bone and Joint Surgery A, vol. 86, no. 7, pp. 1512–1518, 2004. View at Google Scholar · View at Scopus
  9. A. F. Moonen, B. J. Thomassen, N. T. Knoors, J. J. van Os, A. D. Verburg, and P. Pilot, “Pre-operative injections of epoetin-α versus post-operative retransfusion of autologous shed blood in total hip and knee replacement: a prospective randomised clinical trial,” Journal of Bone and Joint Surgery B, vol. 90, no. 8, pp. 1079–1083, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Wilson, G. L. Yao, J. Raftery et al., “A systematic review and economic evaluation of epoetin α, epoetin β and darbepoetin α in anaemia associated with cancer, especially that attributable to cancer treatment,” Health Technology Assessment, vol. 11, no. 13, pp. 1–202, 2007. View at Google Scholar · View at Scopus
  11. B. E. Bierbaum, J. J. Callaghan, J. O. Galante, H. E. Rubash, R. E. Tooms, and R. B. Welch, “An analysis of blood management in patients having a total hip or knee arthroplasty,” Journal of Bone and Joint Surgery A, vol. 81, no. 1, pp. 2–10, 1999. View at Google Scholar · View at Scopus
  12. J. A. Salido, L. A. Marín, L. A. Gómez, P. Zorrilla, and C. Martínez, “Preoperative hemoglobin levels and the need for transfusion after prosthetic hip and knee surgery: analysis of predictive factors,” Journal of Bone and Joint Surgery A, vol. 84, no. 2, pp. 216–220, 2002. View at Google Scholar · View at Scopus
  13. X. Liu, X. Zhang, Y. Chen, Q. Wang, Y. Jiang, and B. Zeng, “Hidden blood loss after total Hip arthroplasty,” Journal of Arthroplasty, vol. 26, no. 7, pp. 1100–1105, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. K. Sehat, R. Evans, and J. Newman, “Hidden blood loss following hip and knee arthroplasty: correct management of blood loss should take hidden loss into account,” Journal of Bone and Joint Surgery B, vol. 86, no. 4, pp. 561–565, 2004. View at Google Scholar · View at Scopus
  15. A. T. Berman, A. E. Geissele, and S. J. Bosacco, “Blood loss with total knee arthroplasty,” Clinical Orthopaedics and Related Research, no. 234, pp. 137–138, 1988. View at Google Scholar · View at Scopus
  16. F. D. Cushner and R. J. Friedman, “Blood loss in total knee arthroplasty,” Clinical Orthopaedics and Related Research, no. 269, pp. 98–101, 1991. View at Google Scholar · View at Scopus
  17. F. D. Cushner, I. Foley, D. Kessler, G. Scuderi, and W. N. Scott, “Blood management in revision total knee arthroplasty,” Clinical Orthopaedics and Related Research, no. 404, pp. 247–255, 2002. View at Google Scholar · View at Scopus
  18. C. Couvret, M. Laffon, A. Baud, V. Payen, P. Burdin, and J. Fusciardi, “A restrictive use of both autologous donation and recombinant human erythropoietin is an efficient policy for primary total hip or knee arthroplasty,” Anesthesia and Analgesia, vol. 99, no. 1, pp. 262–271, 2004. View at Google Scholar · View at Scopus
  19. W. S. Green, P. Toy, and K. J. Bozic, “Cost minimization analysis of preoperative erythropoietin versus autologous and allogeneic blood donation in total joint arthroplasty,” Journal of Arthroplasty, vol. 25, no. 1, pp. 93–96, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. M. C. Munin, T. E. Rudy, N. W. Glynn, L. S. Crossett, and H. E. Rubash, “Early inpatient rehabilitation after elective hip and knee arthroplasty,” Journal of the American Medical Association, vol. 279, no. 11, pp. 847–852, 1998. View at Publisher · View at Google Scholar · View at Scopus
  21. J. de Andrade, M. Jove, G. Landon, D. Frei, M. Guilfoyle, and D. C. Young, “Baseline hemoglobin as a predictor of risk of transfusion and response to Epoetin α in orthopedic surgery patients,” American journal of Orthopedics, vol. 25, no. 8, pp. 533–542, 1996. View at Google Scholar · View at Scopus
  22. C. Stowell, H. Chandler, M. Jové, M. Guilfoyle, and M. Wacholtz, “An open-label, randomized study to compare the safety and efficacy of perioperative epoetin α with preoperative autologous blood donation in total joint arthroplasty,” Orthopedics, vol. 22, supplement 1, pp. s105–s112, 1999. View at Google Scholar · View at Scopus
  23. J. Erskine, C. Fraser, and R. Simpson, “Blood loss with knee joint replacement,” Journal of the Royal College of Surgeons of Edinburgh, vol. 26, no. 5, pp. 295–297, 1981. View at Google Scholar · View at Scopus
  24. K. McManus, M. Velchik, A. Alavi, and P. Lotke, “Non-invasive assessment of postoperative bleeding in TKA patients with Tc-99m RNCs,” Journal of Nuclear Medicine, vol. 28, pp. 565–567, 1987. View at Google Scholar
  25. N. R. Fahmy and D. G. Patel, “Hemostatic changes and postoperative deep-vein thrombosis associated with use of a pneumatic tourniquet,” Journal of Bone and Joint Surgery A, vol. 63, no. 3, pp. 461–465, 1981. View at Google Scholar · View at Scopus
  26. J. Petäjä, P. Myllynen, G. Myllylä, and E. Vahtera, “Fibrinolysis after application of a pneumatic tourniquet,” Acta Chirurgica Scandinavica, vol. 153, no. 11-12, pp. 647–651, 1987. View at Google Scholar · View at Scopus
  27. B. Risberg, “The response of the fibrinolytic system in trauma,” Acta Chirurgica Scandinavica, vol. 522, pp. 245–271, 1985. View at Google Scholar · View at Scopus
  28. G. Benoni and H. Fredin, “Fibrinolytic inhibition with tranexamic acid reduces blood loss and blood transfusion after knee arthroplasty: a prospective, randomised, double-blind study of 86 patients,” Journal of Bone and Joint Surgery B, vol. 78, no. 3, pp. 434–440, 1996. View at Google Scholar · View at Scopus
  29. S. Hiippala, L. Strid, M. Wennerstrand et al., “Tranexamic acid (Cyklokapron) reduces perioperative blood loss associated with total knee arthroplasty,” British Journal of Anaesthesia, vol. 74, no. 5, pp. 534–537, 1995. View at Google Scholar · View at Scopus
  30. W. W. Tang, R. A. Stead, and D. A. Goodkin, “Effects of epoetin α on hemostasis in chronic renal failure,” American Journal of Nephrology, vol. 18, no. 4, pp. 263–273, 1998. View at Publisher · View at Google Scholar · View at Scopus
  31. T. Coleman and M. Brines, “Science review: recombinant human erthyropoietin in critical illness: a role beyond anemia?” Critical Care, vol. 8, no. 5, pp. 337–341, 2004. View at Publisher · View at Google Scholar · View at Scopus
  32. K. Maiese, F. Li, and Z. Z. Chong, “New avenues of exploration for erythropoietin,” Journal of the American Medical Association, vol. 293, no. 1, pp. 90–95, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Brines and A. Cerami, “Discovering erythropoietin's extra-hematopoietic functions: biology and clinical promise,” Kidney International, vol. 70, no. 2, pp. 246–250, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Henke, R. Laszig, C. Rübe et al., “Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial,” The Lancet, vol. 362, no. 9392, pp. 1255–1260, 2003. View at Publisher · View at Google Scholar · View at Scopus
  35. B. Leyland-Jones, V. Semiglazov, M. Pawlicki et al., “Maintaining normal hemoglobin levels with epoetin α in mainly nonanemic patients with metastatic breast cancer receiving first-line chemotherapy: a survival study,” Journal of Clinical Oncology, vol. 23, no. 25, pp. 5960–5972, 2005. View at Publisher · View at Google Scholar · View at Scopus
  36. J. Bohlius, J. Wilson, J. Seidenfeld et al., “Recombinant human erythropoietins and cancer patients: updated meta-analysis of 57 studies including 9353 patients,” Journal of the National Cancer Institute, vol. 98, no. 10, pp. 708–714, 2006. View at Publisher · View at Google Scholar · View at Scopus
  37. P. Juelsgaard, U. T. Larsen, J. V. Sorensen, F. Madsen, and K. Soballe, “Hypotensive epidural anesthesia in total knee replacement without tourniquet: reduced blood loss and transfusion,” Regional Anesthesia and Pain Medicine, vol. 26, no. 2, pp. 105–110, 2001. View at Publisher · View at Google Scholar · View at Scopus